Trial no.:
|
PACTR202009852042130 |
Date of Approval:
|
22/09/2020 |
Trial Status:
|
Retrospective registration - This trial was registered after enrolment of the first participant |
|
TRIAL DESCRIPTION |
Public title
|
Effects of Levonorgestrel Intrauterine System versus Copper intrauterine device on uterine artery Doppler indices |
Official scientific title |
Effects of Levonorgestrel Intrauterine System versus Copper intrauterine device on uterine artery Doppler indices |
Brief summary describing the background
and objectives of the trial
|
Intra uterine contraceptive devises (copper device or levonorgestrel releasing intrauterine system/ LNG- IUS) are considered long acting reversible contraceptives with long term efficacy that resembles sterilization (1). However, both were associated with bothering side effects as prolonged/irregular bleeding and heavy menstrual bleeding in LNG- IUS and copper IUD users, respectively (2, 3). However, the LNG- IUS was associated with atrophic changes in the endometrium and reduced menstrual blood loss (4). It also was associated with changes in the endometrial vasculature as demonstrated in endometrial biopsies in the form of decreased mean vascular density and increased mean vessel area (5). Recognizing the changes in the uterine vasculature rendered to IUD usage would be helpful during patient counseling when they request contraception (6) as up to 20% of the copper IUD users request removal because of the side effects (7). The available research documented conflicting results about the effect of the LNG- IUS on uterine artery Doppler indices (6, 8-13). Additionally, conflicting results exist regarding the relation between the copper IUD and increased menstrual blood loss (14- 16). The current study aimed at evaluating the effect of LNG- IUS and copper IUD on uterine vasculature after 3 months of use. |
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
Obstetrics and Gynecology |
Sub-Disease(s) or condition(s) being studied |
family planning |
Purpose of the trial |
Supportive care |
Anticipated trial start date |
01/11/2019 |
Actual trial start date |
|
Anticipated date of last follow up |
31/08/2020 |
Actual Last follow-up date |
|
Anticipated target sample size (number of participants) |
66 |
Actual target sample size (number of participants) |
|
Recruitment status |
Completed |
Publication URL |
|
|